InfuSystem, Sanara MedTech to distribute chemo-relief device
By HME News Staff
Updated 10:00 AM CDT, Thu September 12, 2024
ROCHESTER, Mich. – InfuSystem and Sanara MedTech Inc. have executed an exclusive U.S. distribution agreement with ChemoMouthpiece, a device for the treatment of oral mucositis in chemotherapy patients. “Sanara and InfuSystem entered into our partnership to bring together our combined technical, operational and commercial strengths to deliver proprietary efficacious products to patients,” said Rich Dilorio, CEO, InfuSystem. “We believe this exclusive agreement, which builds on our partnership, will allow us to do that by offering the Chemo Mouthpiece, an oral cryotherapy device, bringing potential relief to thousands of cancer patients suffering from oral mucositis.” The Chemo Mouthpiece cools down the entire oral cavity, causing vasoconstriction, which in effect slows and reduces the flow of chemotherapy in the oral cavity, thus greatly reducing the risk of developing oral mucositis.
Comments